{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:05:42Z","timestamp":1795122342351,"version":"4.10.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7984","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Effective pandemic preparedness relies on anticipating viral mutations that are able to evade host immune responses to facilitate vaccine and therapeutic design. However, current strategies for viral evolution prediction are not available early in a pandemic\u2014experimental approaches require host polyclonal antibodies to test against\n                    <jats:sup>1\u201316<\/jats:sup>\n                    , and existing computational methods draw heavily from current strain prevalence to make reliable predictions of variants of concern\n                    <jats:sup>17\u201319<\/jats:sup>\n                    . To address this, we developed EVEscape, a generalizable modular framework that combines fitness predictions from a deep learning model of historical sequences with biophysical and structural information. EVEscape quantifies the viral escape potential of mutations at scale and has the advantage of being applicable before surveillance sequencing, experimental scans or three-dimensional structures of antibody complexes are available. We demonstrate that EVEscape, trained on sequences available before 2020, is as accurate as high-throughput experimental scans at anticipating pandemic variation for SARS-CoV-2 and is generalizable to other viruses including influenza, HIV and understudied viruses with pandemic potential such as Lassa and Nipah. We provide continually revised escape scores for all current strains of SARS-CoV-2 and predict probable further mutations to forecast emerging strains as a tool for continuing vaccine development (\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/evescape.org\">evescape.org<\/jats:ext-link>\n                    ).\n                  <\/jats:p>","DOI":"10.1038\/s41586-023-06617-0","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T12:02:04Z","timestamp":1697025724000},"page":"818-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":229,"title":["Learning from prepandemic data to forecast viral escape"],"prefix":"10.1038","volume":"622","author":[{"given":"Nicole N.","family":"Thadani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5931-6622","authenticated-orcid":false,"given":"Sarah","family":"Gurev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Notin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Rollins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3266-9917","authenticated-orcid":false,"given":"Daniel","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-2078","authenticated-orcid":false,"given":"Yarin","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-2281","authenticated-orcid":false,"given":"Debora S.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"6617_CR1","doi-asserted-by":"publisher","first-page":"e20201181","DOI":"10.1084\/jem.20201181","volume":"217","author":"F Schmidt","year":"2020","unstructured":"Schmidt, F. et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J. Exp. Med. 217, e20201181 (2020).","journal-title":"J. Exp. Med."},{"key":"6617_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41564-021-00972-2","volume":"6","author":"J Dong","year":"2021","unstructured":"Dong, J. et al. Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail. Nat. Microbiol. 6, 1233\u20131244 (2021).","journal-title":"Nat. Microbiol."},{"key":"6617_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 Spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44\u201357.e9 (2021).","journal-title":"Cell Host Microbe"},{"key":"6617_CR4","doi-asserted-by":"crossref","unstructured":"Greaney, A. J. et al. Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nat. Commun. 12, 4196 (2021).","DOI":"10.1038\/s41467-021-24435-8"},{"key":"6617_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463\u2013476.e6 (2021).","journal-title":"Cell Host Microbe"},{"key":"6617_CR6","doi-asserted-by":"publisher","first-page":"eabi9915","DOI":"10.1126\/scitranslmed.abi9915","volume":"13","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Sci. Transl Med. 13, eabi9915 (2021).","journal-title":"Sci. Transl Med."},{"key":"6617_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850\u2013854 (2021).","journal-title":"Science"},{"key":"6617_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","volume":"597","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature 597, 97\u2013102 (2021).","journal-title":"Nature"},{"key":"6617_CR9","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.xcrm.2021.100255","volume":"2","author":"TN Starr","year":"2021","unstructured":"Starr, T. N., Greaney, A. J., Dingens, A. S. & Bloom, J. D. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. Cell Rep. Med. 2, 100255 (2021).","journal-title":"Cell Rep. Med."},{"key":"6617_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-021-03817-4","volume":"597","author":"MA Tortorici","year":"2021","unstructured":"Tortorici, M. A. et al. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature 597, 103\u2013108 (2021).","journal-title":"Nature"},{"key":"6617_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature 602, 657\u2013663 (2022).","journal-title":"Nature"},{"key":"6617_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"6617_CR13","doi-asserted-by":"publisher","first-page":"e1010248","DOI":"10.1371\/journal.ppat.1010248","volume":"18","author":"AJ Greaney","year":"2022","unstructured":"Greaney, A. J. et al. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy. PLoS Pathog. 18, e1010248 (2022).","journal-title":"PLoS Pathog."},{"key":"6617_CR14","doi-asserted-by":"publisher","first-page":"e1010592","DOI":"10.1371\/journal.ppat.1010592","volume":"18","author":"AJ Greaney","year":"2022","unstructured":"Greaney, A. J. et al. The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes. PLoS Pathog. 18, e1010592 (2022).","journal-title":"PLoS Pathog."},{"key":"6617_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03665-3","volume":"9","author":"MB Doud","year":"2018","unstructured":"Doud, M. B., Lee, J. M. & Bloom, J. D. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. Nat. Commun. 9, 1386 (2018).","journal-title":"Nat. Commun."},{"key":"6617_CR16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.immuni.2018.12.017","volume":"50","author":"AS Dingens","year":"2019","unstructured":"Dingens, A. S., Arenz, D., Weight, H., Overbaugh, J. & Bloom, J. D. An antigenic atlas of HIV-1 escape from broadly neutralizing antibodies distinguishes functional and structural epitopes. Immunity 50, 520\u2013532.e3 (2019).","journal-title":"Immunity"},{"key":"6617_CR17","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/science.abm1208","volume":"376","author":"F Obermeyer","year":"2022","unstructured":"Obermeyer, F. et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness. Science 376, 1327\u20131332 (2022).","journal-title":"Science"},{"key":"6617_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3390\/v13050935","volume":"13","author":"F Pucci","year":"2021","unstructured":"Pucci, F. & Rooman, M. Prediction and evolution of the molecular fitness of SARS-CoV-2 variants: introducing SpikePro. Viruses 13, 935 (2021).","journal-title":"Viruses"},{"key":"6617_CR19","doi-asserted-by":"publisher","first-page":"106618","DOI":"10.1016\/j.compbiomed.2023.106618","volume":"155","author":"K Beguir","year":"2023","unstructured":"Beguir, K. et al. Early computational detection of potential high-risk SARS-CoV-2 variants. Comput. Biol. Med. 155, 106618 (2023).","journal-title":"Comput. Biol. Med."},{"key":"6617_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","volume":"599","author":"J Frazer","year":"2021","unstructured":"Frazer, J. et al. Disease variant prediction with deep generative models of evolutionary data. Nature 599, 91\u201395 (2021).","journal-title":"Nature"},{"key":"6617_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nbt.3769","volume":"35","author":"TA Hopf","year":"2017","unstructured":"Hopf, T. A. et al. Mutation effects predicted from sequence co-variation. Nat. Biotechnol. 35, 128\u2013135 (2017).","journal-title":"Nat. Biotechnol."},{"key":"6617_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41592-018-0138-4","volume":"15","author":"AJ Riesselman","year":"2018","unstructured":"Riesselman, A. J., Ingraham, J. B. & Marks, D. S. Deep generative models of genetic variation capture the effects of mutations. Nat. Methods 15, 816\u2013822 (2018).","journal-title":"Nat. Methods"},{"key":"6617_CR23","doi-asserted-by":"publisher","first-page":"e00631","DOI":"10.7554\/eLife.00631","volume":"2","author":"LI Gong","year":"2013","unstructured":"Gong, L. I., Suchard, M. A. & Bloom, J. D. Stability-mediated epistasis constrains the evolution of an influenza protein. eLife 2, e00631 (2013).","journal-title":"eLife"},{"key":"6617_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1126\/science.abo7896","volume":"377","author":"TN Starr","year":"2022","unstructured":"Starr, T. N. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 377, 420\u2013424 (2022).","journal-title":"Science"},{"key":"6617_CR25","doi-asserted-by":"publisher","first-page":"e34420","DOI":"10.7554\/eLife.34420","volume":"7","author":"HK Haddox","year":"2018","unstructured":"Haddox, H. K., Dingens, A. S., Hilton, S. K., Overbaugh, J. & Bloom, J. D. Mapping mutational effects along the evolutionary landscape of HIV envelope. eLife 7, e34420 (2018).","journal-title":"eLife"},{"key":"6617_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/v8060155","volume":"8","author":"MB Doud","year":"2016","unstructured":"Doud, M. B. & Bloom, J. D. Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin. Viruses 8, 155 (2016).","journal-title":"Viruses"},{"key":"6617_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.aaz5143","volume":"368","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. et al. Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses. Science 368, 1335\u20131340 (2020).","journal-title":"Science"},{"key":"6617_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/v12020241","volume":"12","author":"JI Roop","year":"2020","unstructured":"Roop, J. I., Cassidy, N. A., Dingens, A. S., Bloom, J. D. & Overbaugh, J. Identification of HIV-1 envelope mutations that enhance entry using macaque CD4 and CCR5. Viruses 12, 241 (2020).","journal-title":"Viruses"},{"key":"6617_CR29","doi-asserted-by":"publisher","first-page":"e1005988","DOI":"10.1371\/journal.ppat.1005988","volume":"12","author":"M Duenas-Decamp","year":"2016","unstructured":"Duenas-Decamp, M., Jiang, L., Bolon, D. & Clapham, P. R. Saturation mutagenesis of the HIV-1 envelope CD4 binding loop reveals residues controlling distinct trimer conformations. PLoS Pathog. 12, e1005988 (2016).","journal-title":"PLoS Pathog."},{"key":"6617_CR30","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295\u20131310.e20 (2020).","journal-title":"Cell"},{"key":"6617_CR31","doi-asserted-by":"publisher","first-page":"eabf1738","DOI":"10.1126\/sciadv.abf1738","volume":"7","author":"KK Chan","year":"2021","unstructured":"Chan, K. K., Tan, T. J. C., Narayanan, K. K. & Procko, E. An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants. Sci. Adv. 7, eabf1738 (2021).","journal-title":"Sci. Adv."},{"key":"6617_CR32","doi-asserted-by":"publisher","first-page":"e77433","DOI":"10.7554\/eLife.77433","volume":"11","author":"JM Flynn","year":"2022","unstructured":"Flynn, J. M. et al. Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms. eLife 11, e77433 (2022).","journal-title":"eLife"},{"key":"6617_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/prot.21983","volume":"72","author":"C-P Lin","year":"2008","unstructured":"Lin, C.-P. et al. Deriving protein dynamical properties from weighted protein contact number. Proteins 72, 929\u2013935 (2008).","journal-title":"Proteins"},{"key":"6617_CR34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/256705a0","volume":"256","author":"C Chothia","year":"1975","unstructured":"Chothia, C. & Janin, J. Principles of protein\u2013protein recognition. Nature 256, 705\u2013708 (1975).","journal-title":"Nature"},{"key":"6617_CR35","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024\u20131042.e21 (2020).","journal-title":"Cell"},{"key":"6617_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","volume":"29","author":"G Cerutti","year":"2021","unstructured":"Cerutti, G. et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe 29, 819\u2013833.e7 (2021).","journal-title":"Cell Host Microbe"},{"key":"6617_CR37","doi-asserted-by":"publisher","first-page":"e2113118119","DOI":"10.1073\/pnas.2113118119","volume":"119","author":"J Rodriguez-Rivas","year":"2022","unstructured":"Rodriguez-Rivas, J., Croce, G., Muscat, M. & Weigt, M. Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes. Proc. Natl Acad. Sci. USA 119, e2113118119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"6617_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.abe1502","volume":"370","author":"S Bangaru","year":"2020","unstructured":"Bangaru, S. et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Science 370, 1089\u20131094 (2020).","journal-title":"Science"},{"key":"6617_CR39","doi-asserted-by":"publisher","first-page":"e1010631","DOI":"10.1371\/journal.ppat.1010631","volume":"18","author":"T Ginex","year":"2022","unstructured":"Ginex, T. et al. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation. PLoS Pathog. 18, e1010631 (2022).","journal-title":"PLoS Pathog."},{"key":"6617_CR40","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1280819\/v1","author":"LP Zhao","year":"2022","unstructured":"Zhao, L. P. et al. Rapidly identifying new Coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy. Preprint at\u00a0Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-1280819\/v1 (2022).","journal-title":"Res. Sq."},{"key":"6617_CR41","doi-asserted-by":"publisher","first-page":"103944","DOI":"10.1016\/j.ebiom.2022.103944","volume":"78","author":"T Tada","year":"2022","unstructured":"Tada, T. et al. Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies. eBioMedicine 78, 103944 (2022).","journal-title":"eBioMedicine"},{"key":"6617_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1126\/science.abd7331","volume":"371","author":"B Hie","year":"2021","unstructured":"Hie, B., Zhong, E. D., Berger, B. & Bryson, B. Learning the language of viral evolution and escape. Science 371, 284\u2013288 (2021).","journal-title":"Science"},{"key":"6617_CR43","doi-asserted-by":"publisher","unstructured":"Notin, P. et al. TranceptEVE: combining family-specific and family-agnostic models of protein sequences for improved fitness prediction. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.12.07.519495 (2022).","DOI":"10.1101\/2022.12.07.519495"},{"key":"6617_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28246-3","volume":"13","author":"DS Smyth","year":"2022","unstructured":"Smyth, D. S. et al. Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewater. Nat. Commun. 13, 635 (2022).","journal-title":"Nat. Commun."},{"key":"6617_CR45","doi-asserted-by":"publisher","first-page":"e0127822","DOI":"10.1128\/mbio.01278-22","volume":"13","author":"TK Buck","year":"2022","unstructured":"Buck, T. K. et al. Neutralizing antibodies against Lassa virus lineage I. mBio 13, e0127822 (2022).","journal-title":"mBio"},{"key":"6617_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/infdis\/jiv449","volume":"213","author":"V Borisevich","year":"2016","unstructured":"Borisevich, V. et al. Escape from monoclonal antibody neutralization affects henipavirus fitness in vitro and in vivo. J. Infect. Dis. 213, 448\u2013455 (2016).","journal-title":"J. Infect. Dis."},{"key":"6617_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1126\/science.abm5561","volume":"375","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Architecture and antigenicity of the Nipah virus attachment glycoprotein. Science 375, 1373\u20131378 (2022).","journal-title":"Science"},{"key":"6617_CR48","doi-asserted-by":"publisher","first-page":"e1003684","DOI":"10.1371\/journal.ppat.1003684","volume":"9","author":"K Xu","year":"2013","unstructured":"Xu, K. et al. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. PLoS Pathog. 9, e1003684 (2013).","journal-title":"PLoS Pathog."},{"key":"6617_CR49","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","volume":"26","author":"HV Dang","year":"2019","unstructured":"Dang, H. V. et al. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nat. Struct. Mol. Biol. 26, 980\u2013987 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"6617_CR50","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41594-021-00584-8","volume":"28","author":"HV Dang","year":"2021","unstructured":"Dang, H. V. et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nat. Struct. Mol. Biol. 28, 426\u2013434 (2021).","journal-title":"Nat. Struct. Mol. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06617-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06617-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06617-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T03:03:47Z","timestamp":1698289427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-06617-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":50,"journal-issue":{"issue":"7984","published-print":{"date-parts":[[2023,10,26]]}},"alternative-id":["6617"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-06617-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.21.501023","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S.M. is an advisor for Dyno Therapeutics, Octant, Jura Bio, Tectonic Therapeutic and Genentech and is a cofounder of Seismic Therapeutic. C.S. is an advisor for CytoReason Ltd. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}